Clal Insurance Enterprises Holdings Ltd. (TLV:CLIS)
29,000
+560 (1.97%)
May 8, 2026, 1:49 PM IDT
TLV:CLIS Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 8,837 | 8,391 | 9,495 | 9,844 | 9,012 |
Total Interest & Dividend Income | 5,507 | 4,110 | 3,660 | 2,757 | 2,088 |
Gain (Loss) on Sale of Investments | - | - | 5,571 | -6,948 | 11,766 |
Non-Insurance Activities Revenue | 1,740 | 1,554 | 1,083 | - | - |
Other Revenue | 190 | 180 | 390 | 383 | 339 |
| 17,124 | 15,040 | 21,458 | 7,234 | 24,980 | |
Revenue Growth (YoY) | 13.86% | -29.91% | 196.63% | -71.04% | 69.83% |
Policy Benefits | 6,852 | 6,566 | 15,391 | 3,741 | 20,273 |
Policy Acquisition & Underwriting Costs | - | - | 2,084 | 1,970 | 1,799 |
Selling, General & Administrative | - | - | 1,604 | 1,152 | 1,160 |
Provision for Bad Debts | 169 | 216 | 411 | - | - |
Non-Insurance Activities Expense | 1,522 | 1,219 | 905 | - | - |
Other Operating Expenses | 1,783 | 1,561 | 40 | 18 | 9 |
Reinsurance Income or Expense | -687 | -758 | - | - | - |
Total Operating Expenses | 11,013 | 10,320 | 20,452 | 6,896 | 23,265 |
Operating Income | 6,111 | 4,720 | 1,006 | 338 | 1,715 |
Interest Expense | -852 | -779 | -651 | -213 | -219 |
Earnings From Equity Investments | 21 | 14 | 8 | 3 | 29 |
Currency Exchange Gain (Loss) | -6 | -5 | 12 | 27 | -9 |
Other Non Operating Income (Expenses) | -1,885 | -1,665 | -2 | 1 | - |
EBT Excluding Unusual Items | 3,389 | 2,285 | 373 | 156 | 1,516 |
Asset Writedown | - | - | -26 | 39 | 82 |
Other Unusual Items | - | - | - | - | -17 |
Pretax Income | 3,389 | 2,285 | 347 | 195 | 1,581 |
Income Tax Expense | 1,104 | 739 | 124 | 68 | 494 |
Earnings From Continuing Ops. | 2,285 | 1,546 | 223 | 127 | 1,087 |
Minority Interest in Earnings | -7 | -6 | -3 | -6 | -5 |
Net Income | 2,278 | 1,540 | 220 | 121 | 1,082 |
Net Income to Common | 2,278 | 1,540 | 220 | 121 | 1,082 |
Net Income Growth | 47.92% | 600.00% | 81.82% | -88.82% | 146.65% |
Shares Outstanding (Basic) | 80 | 79 | 78 | 74 | 68 |
Shares Outstanding (Diluted) | 83 | 79 | 79 | 74 | 68 |
Shares Change (YoY) | 4.31% | 0.56% | 6.33% | 9.72% | 0.14% |
EPS (Basic) | 28.57 | 19.47 | 2.83 | 1.64 | 16.00 |
EPS (Diluted) | 27.47 | 19.38 | 2.79 | 1.62 | 15.97 |
EPS Growth | 41.74% | 594.62% | 72.22% | -89.86% | 146.45% |
Free Cash Flow | 2,450 | 1,536 | -4,344 | -2,609 | 7,061 |
Free Cash Flow Per Share | 29.55 | 19.33 | -54.96 | -35.10 | 104.23 |
Operating Margin | 35.69% | 31.38% | 4.69% | 4.67% | 6.87% |
Profit Margin | 13.30% | 10.24% | 1.03% | 1.67% | 4.33% |
Free Cash Flow Margin | 14.31% | 10.21% | -20.24% | -36.07% | 28.27% |
EBITDA | 6,188 | 4,785 | 1,065 | 660 | 2,040 |
EBITDA Margin | 36.14% | 31.81% | 4.96% | 9.12% | 8.17% |
D&A For EBITDA | 77 | 65 | 59 | 322 | 325 |
EBIT | 6,111 | 4,720 | 1,006 | 338 | 1,715 |
EBIT Margin | 35.69% | 31.38% | 4.69% | 4.67% | 6.87% |
Effective Tax Rate | 32.58% | 32.34% | 35.73% | 34.87% | 31.25% |
Revenue as Reported | - | - | 21,464 | 7,329 | 25,057 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.